News & Events

Octapharma USA Sponsors NHF Annual Meeting, Shares Inspirational Bleeding Disorders Community Achievements

HOBOKEN, N.J. (August 29, 2017) – Octapharma USA sponsored the National Hemophilia Foundation’s 69th Annual Meeting in Chicago and provided a patient symposium sharing the inspirational stories of three young men with bleeding disorders, including Chris Bombardier, who recently became …
More

Octapharma USA Announces FDA Approval of NUWIQ® New Product Strengths, Expanding Hemophilia A Patient Treatment Options

New Higher Vial Strengths will Provide Added Dosing Flexibility & Convenience HOBOKEN, N.J. (August 22, 2017) – Octapharma USA today announced the U.S. Food and Drug Administration (FDA) has approved new product strengths for NUWIQ®, offering added convenience by potentially …
More

Octapharma USA Grant Funds First National Camp Exchange Program for Bleeding Disorders Community Camps

HOBOKEN, N.J. (July 13, 2017) – Octapharma USA has provided a grant to fund the first National Camp Exchange (NCE) for the bleeding disorders community, an adjunct program of the North American Camping Conference of Hemophilia Organizations (NACCHO). NCE will …
More

Octapharma USA Sponsors ‘Hope Ignites: Stories to Inspire’ Program at Hemophilia Federation of America Annual Symposium

HOBOKEN, N.J. (April 7, 2017) – Octapharma USA today sponsored the patient symposium “Hope Ignites: Stories to Inspire,” during the Hemophilia Federation of America (HFA) Annual Symposium in Providence, Rhode Island. The Octapharma symposium introduced attendees to the inspiring lives …
More